Could a Latin American Cannabis Trade Bloc Actually Form?
Photo by PROJETO CAFÉ GATO-MOURISCO via Unsplash.
There's no cannabis equivalent of Mercosur sitting on anyone's desk in Brasília, Bogotá, or Montevideo. No treaty text, no proposed secretariat, no flag. And yet if you look at what's actually moving across South American borders right now -- licensed product, capital, corporate ownership stakes -- the picture looks less like five isolated national experiments and more like a trade network that's already half-built, just without the paperwork that would make it official. Licensing regimes have matured. Export corridors between specific countries have become predictable enough to plan a business around. Cross-border acquisitions have started consolidating competitors into regional groups. None of that required a bloc. It just happened, deal by deal, the way commercial integration usually happens before the politicians catch up.
The moment that crystallizes the tension sits in February 2026: Brazil's health regulator authorized domestic cannabis cultivation for the first time, a move that could eventually let Brazilian growers supply Brazilian patients directly. The catch is that Brazil is also, right now, Colombia's single largest export customer -- by a wide and growing margin. Those two facts pull in opposite directions. Domestic Brazilian cultivation could integrate with Colombian supply chains, with Brazilian processors and distributors building on top of Colombian raw material the way plenty of agricultural supply chains layer across borders. Or it could simply replace Colombian imports over time, in which case Brazil's incentive to lock in favorable cross-border trade terms with its neighbors quietly evaporates. Which path wins out says a lot about whether informal regional trade hardens into something bloc-like or just stays informal indefinitely. That's the actual question this piece is trying to answer: what, specifically, would have to happen -- politically and economically -- for Latin America's cannabis trade to go from de facto to de jure, and what's currently standing in the way.
The Region's Patchwork of National Frameworks, Circa 2026
Photo by Walter Otto via Unsplash.
Five countries now run formal medical cannabis licensing frameworks under national law -- Colombia, Uruguay, Brazil, Argentina, and increasingly Ecuador's export-oriented regime. That's a meaningful shift from even three years ago, when Uruguay and Colombia were the only serious legal-export players and everyone else was either fully prohibitionist or operating in a gray zone of court-ordered patient exemptions. The expansion matters, but so does the fact that each country built its system on its own schedule, with its own definitions, and nobody coordinated any of it.
Colombia's framework is still the most developed, and it still runs on Decree 811 of 2021: a licensing structure, cultivation quotas allocated through the Fondo Nacional de Estupefacientes, sanitary registration through INVIMA, and export authorizations issued shipment by shipment rather than as blanket permits. Colombia tightened that system further with Resolution 539 of 2025, adding compliance requirements that increased friction for exporters even as volumes grew. It's a system built for control first and trade facilitation second -- which makes sense for a country managing the legacy of decades-long narcotics enforcement, but it also means Colombian exporters operate inside a tighter regulatory corridor than some competitors.
Brazil's shift is the bigger structural event. On February 3, 2026, ANVISA, the national health regulator, published four resolutions -- RDC 1,012 through 1,015 -- authorizing domestic cultivation under a 0.3% THC cap, with an effective date in August 2026. That's not a small patient population being served: Brazil's medical cannabis patient registry already exceeds 873,000 people, built almost entirely on imported product and compounded formulations prescribed through existing health channels. Authorizing domestic growing against a base that large is a genuinely different order of market event than, say, Uruguay's considerably smaller rollout a decade earlier.
Meanwhile, even within a single country, regulatory follow-through isn't guaranteed. Colombia has had a pharmacy-dispensing reform circulating in draft form since 2025 that still hasn't been finalized or published. If a government with a decade of cannabis-licensing experience can't close out a domestic reform on a predictable timeline, that's a useful caution against assuming cross-border harmonization would move any faster. This is exactly the kind of regulatory asymmetry -- different THC caps, different registries, different licensing bodies, different paces of reform -- that trade blocs like the EU or Mercosur exist to smooth over. Right now, nothing is smoothing it over. Each country is simply building its own system and hoping the neighbors' systems are compatible enough to trade with.
]Trade Is Already Happening -- Just Without a Treaty
In 2025, Brazil accounted for roughly 32% of Colombia's cannabis exports, making it a significant single-country destination compared to the remaining 68% spread across other markets.
Set the regulatory patchwork aside for a second, because the commercial reality has already outrun it. Colombia is the region's largest cannabis exporter by license volume -- a recent Spanish-language trade analysis counted 1,916 active licenses in the country, dwarfing every other national market. That volume has to go somewhere, and increasingly it goes to Brazil. Brazil now accounts for more than 32% of total Colombian cannabis exports, making it Colombia's single largest customer by a comfortable margin. Given that Brazil's patient registry is still expanding past 873,000 people and domestic cultivation won't even become legally operative until August 2026, that 32% share has looked more like a floor than a ceiling over the past couple of years.
Colombia and Brazil aren't the whole story. Uruguay, the first mover in Latin American legal cannabis, exported more than USD 2 million in cannabis product in 2025 -- modest next to Colombia's volumes, but notable because Uruguay's framework has existed since 2013 and still functions as a reliable, if small, export node. Argentina has export infrastructure either live or actively under construction, and Brazil itself is positioning to become an exporter eventually, not just an importer, once its domestic cultivation sector has time to mature past its own patient base.
The clearest signal that integration is outpacing policy is the corporate consolidation already underway. In 2024, Brazil's Ease Labs acquired Colombia's Plena Global in a deal worth more than US$7 million, forming what's been described as the largest cannabis corporate group in Latin America. That's a cross-border acquisition between two companies operating under two entirely separate national licensing regimes, with no treaty, no mutual-recognition agreement, and no shared regulatory body smoothing the transaction. It happened anyway, because the commercial logic -- combining Colombian cultivation and processing capacity with Brazilian market access and capital -- was strong enough to clear whatever legal friction existed.
This is a familiar historical pattern, and it's worth naming directly: formal trade blocs are usually preceded by exactly this kind of informal commercial integration, not the other way around. Intra-European trade networks and corporate linkages were already dense well before the 1957 Treaty of Rome created the European Economic Community -- the treaty formalized relationships that businesses had already built. If Latin American cannabis trade follows that sequence, what we're watching right now, messy and treaty-free as it is, is the precondition stage. It doesn't guarantee a bloc eventually forms. But it's the same shape as the thing that usually comes before one.
Could Mercosur or CELAC Absorb Cannabis Into Their Mandate?
Photo by Evangeline Shaw via Unsplash.
Look inside the region's actual trade institutions and you won't find cannabis mentioned as a distinct policy category. Mercosur and CELAC, the two bodies with the most plausible mandate to eventually host something bloc-like, currently touch drugs policy only through counter-narcotics cooperation -- frameworks built to coordinate enforcement and interdiction, not legal commercial trade. The February 2024 EU-CELAC summit produced the La Paz declaration, which addresses drug trafficking cooperation explicitly and says nothing about legal cannabis commerce. As of early 2026, there's no evidence of a dedicated cannabis trade bloc proposal inside either organization. That's a fact worth sitting with before getting too far ahead of the current moment.
The more plausible catalyst is indirect: the EU-Mercosur trade agreement, concluded in December 2024 after more than 25 years of on-and-off negotiation. That deal lowers tariffs for Mercosur's full members -- Argentina, Brazil, Paraguay, and Uruguay -- and extends favorable treatment to associate states including Colombia and Ecuador. It is not cannabis-specific in any way, and it still faces ratification hurdles inside the EU, where individual member states and the European Parliament have historically slowed or reshaped trade deals during the ratification stage. Treat this as a structural opening that could someday make cannabis exports more price-competitive on EU-adjacent terms -- not as evidence that anyone intends to use it that way.
There's real historical precedent for a commodity riding into an existing bloc rather than getting its own standalone treaty. Wine didn't get a separate EU treaty -- its trade rules got absorbed into the EU's general agricultural framework once member-state wine industries reached enough scale and political weight to matter. Soy followed a similar path inside Mercosur. ASEAN has done the same with various agricultural commodities over time. The pattern is consistent: blocs generally don't negotiate commodity-specific treaties from scratch; they fold a maturing industry into machinery that already exists.
The counter-case is substantial, though, and shouldn't be waved away. Every Latin American country discussed here is still a signatory to the 1988 UN Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, which remains binding law and creates real legal friction for any formal cross-border cannabis trade framework. A bloc couldn't simply route around that convention -- it would have to navigate it explicitly, the same way individual countries have had to construct medical and industrial carve-outs within their own national drug laws. That's a slower, more legally delicate process than tariff harmonization alone.
Paraguay and the Illicit Market Problem No Bloc Can Ignore
Photo by Sushanta Rokka via Unsplash.
Any conversation about a legal Latin American cannabis bloc has to reckon with Paraguay, because Paraguay is currently South America's dominant illicit-market cannabis supplier -- not a marginal player, but the regional center of gravity for unlicensed production. That fact alone complicates the diplomatic optics of any legal bloc built among its neighbors. Regionally, more than 2,000 metric tons of cannabis were seized in 2024 alone, a figure that dwarfs the legal export volumes discussed above and is a blunt reminder of just how much illicit supply still exists alongside the formal licensing systems Colombia, Brazil, and Uruguay have built.
A legal trade bloc anchored by Colombia, Brazil, Uruguay, and Argentina would, in effect, be defining itself in opposition to a neighbor's illicit economy. That's not a hypothetical problem -- there's a direct precedent in how EU accession negotiations with Balkan candidate states have worked. The EU has repeatedly required organized-crime and rule-of-law benchmarks to be met before those countries could move forward on trade integration, precisely because admitting a member with an unaddressed illicit economy undermines the credibility of the whole bloc's claim to run clean, traceable supply chains. Any Latin American legal cannabis framework seeking credibility with the EU or the US would likely face the same expectation.
Here's where it's important to separate fact from speculation. It is fact that Paraguay currently supplies the dominant share of the region's illicit cannabis market and has no operational legal licensing framework comparable to its neighbors'. It is reasoned extrapolation -- not established fact -- to say Paraguay might eventually follow Uruguay's path, which began with legalization in 2013, or Colombia's, which began building its licensing system from 2016 onward. Both of those countries shifted from restrictive or informal markets into regulated export frameworks within a decade once the domestic political will existed. Paraguay could, in principle, follow a similar arc. But nothing currently visible in Paraguayan domestic politics signals that kind of shift is underway or imminent, and it would be overreach to treat it as likely in the near term.
This is precisely the kind of friction point that separates cautious optimism from wishful thinking. A legal bloc's external credibility -- with the EU, with US regulators, with international banks willing to finance cross-border cannabis trade -- depends on being able to visibly and verifiably separate its licensed export channels from illicit regional flows. Until Paraguay's position changes, or until the legal-market countries build mechanisms robust enough to make that separation obvious to outside observers, the Paraguay question remains an open liability that any formal bloc proposal would have to address head-on rather than quietly ignore.
What Would Actually Have to Happen
Photo by Akeyodia - Business Coaching Firm via Unsplash.
If you want a realistic sequence rather than a hopeful one, Mercosur's own formation history is the closest template available. Mercosur didn't begin as a four-country treaty -- it began as bilateral economic integration between Argentina and Brazil in the late 1980s, driven by specific industrial and trade interests between those two governments. Only in 1991 did the Treaty of Asunción expand that bilateral foundation into a four-country bloc by adding Paraguay and Uruguay. Applied to cannabis, the same sequencing logic points toward a Brazil-Colombia bilateral trade arrangement as the most plausible first formal step, simply because that relationship already carries the most trade weight -- Brazil representing over 32% of Colombian cannabis exports is exactly the kind of concentrated bilateral dependency that historically produces bilateral trade terms before anything regional does.
But that forecast hinges entirely on one variable worth watching closely: Brazil's domestic cultivation rollout, effective August 2026. If Brazilian domestic supply starts meaningfully displacing Colombian imports once growers get licensed and operational, Brazil's incentive to negotiate favorable formal trade terms with Colombia weakens rather than strengthens -- why lock in good terms for a supply relationship you're actively trying to need less? That's the scenario that would push things toward competition rather than integration, and it's entirely plausible given how aggressively ANVISA moved in authorizing cultivation against an 873,000-patient base.
On the indirect-benefit side, the EU-Mercosur deal's ratification timeline sets a reasonable outer bound for when any tariff advantages might actually materialize for cannabis exporters. EU ratification fights have run long before -- the EU-Canada CETA agreement took more than seven years to move from signing to provisional application amid member-state objections. If EU-Mercosur follows anything like that pattern, treat several more years as a realistic minimum before any cannabis-relevant tariff benefit becomes concrete, not a near-term event.
The conservative counter-case deserves equal weight here. Harmonizing five countries' different THC caps, different licensing bodies, and different patient registries into anything resembling shared trade rules is a large ask, and Colombia's own stalled pharmacy-dispensing draft -- sitting unfinished since 2025 -- shows that even single-country regulatory follow-through can stall for years without any cross-border complexity added on top. To be precise about what's established versus projected: it is fact that informal trade and cross-border M&A activity in Latin American cannabis are growing, documented by real export share figures and a real corporate acquisition. It is reasoned projection, not fact, that this growth translates into a formal trade bloc within a three-to-seven-year window. The data supports the trend; it doesn't yet support a date.
If something does take shape in the next several years, the more likely outcome isn't a cannabis-specific treaty with its own secretariat and seal. It's cannabis quietly riding into frameworks that already exist -- Mercosur's general trade machinery, or a narrower Brazil-Colombia bilateral arrangement -- the same way wine rode into the EU's agricultural framework and soy rode into Mercosur's, without ever needing a standalone commodity treaty negotiated from scratch. That's a less dramatic story than a new regional bloc being born, but it's the one the historical pattern actually supports.
The single data point worth tracking over diplomatic statements or industry press releases is simple: does Colombia's export share to Brazil keep climbing past 32%, or does it plateau and start giving ground once Brazilian domestic cultivation comes fully online after August 2026? Rising share signals a trade relationship worth formalizing. A plateau, or a decline, signals Brazil quietly substituting its own supply and needing Colombia less -- which would undercut the bilateral-first sequence this piece has laid out as the most plausible path.
And whatever does eventually form will have to answer the Paraguay question directly rather than route around it. The EU didn't admit Balkan candidate states without first demanding rule-of-law and organized-crime benchmarks be met, precisely because ignoring an unresolved illicit economy next door undermines a bloc's credibility with everyone it's trying to trade with. A Latin American legal cannabis framework claiming clean, traceable export channels while a major regional illicit supplier sits unaddressed next door would face exactly the same credibility problem. Until that gets resolved, or at least openly confronted, treat any bloc talk as premature -- the infrastructure is real, the trade is real, but the treaty is still a long way from inevitable.
